Search Results 491-500 of 5744 for albumin

  1. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

    Albumin > 2.7 g/dL; · Total bilirubin ≤ institutional upper limit of normal (ULN). · Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 × ...

  2. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Serum albumin ≥ 30 g/L; Effective contraception during the study period and for 3 months after the last study treatment administration (male and female ...

  3. Mayo Clinic

    ... . IMG-20486765. Home; cc-female-petting-dog_mobile. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact ...

  4. Mayo Clinic

    ... . IMG-20434945. Home; peds-urology-photo-8col-3605211-0003. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in ...

  5. A Study to Evaluate Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers - Mayo Clinic

    Serum albumin >= 2.8 g/dL (obtained within 28 days prior to registration). Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except ...

  6. Mayo Clinic

    Steve Day participated in a research study at Mayo Clinic to try to slow the progression of multiple system atrophy.

  7. Mayo Clinic

    Double your impact on cancer! ... Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge. Give Now.

  8. In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells - Mayo Clinic

    This study will establish in vivo and ex vivo methodologies of assessing the utilization of extracellular nutrients by normal bone marrow plasma cells from ...

  9. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

    Serum albumin ≥3.0 g/dL. Last dose of any prior therapy administered by the following time intervals before the first dose of study drug: Chemotherapy ...

  10. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

    Albumin ≥ 3 g/dL. If female, subject must be either postmenopausal as defined as: Age > 55 years with no menses for 12 or more months without an ...